Skip to content

Efficacy of Powerfit supplement in preventing the recurrence of genital warts

Efficacy of Powerfit supplement in preventing the recurrence of genital warts

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20241207063972N1
Enrollment
100
Registered
2025-01-03
Start date
2024-11-11
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

?????? ???? ??????.

Interventions

Intervention 1: ntervention group: patients are entered in a simple random manner by assigning numbers to the patients and randomly assigning each sample to one of the treatment groups with Powerfit o

Sponsors

Boushehr University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: All male patients aged 18 to 65 years with genital warts who visited the urology clinic in Bushehr for treatment of these warts in 2024.

Exclusion criteria

Exclusion criteria: All male patients between 18 and 65 years old with genital wart lesions Refer to the urology clinic for the treatment of genital warts In 1403

Design outcomes

Primary

MeasureTime frame
Male patients between 18 and 65 years old with genital wart lesions. Timepoint: 6 month. Method of measurement: Independent t-tests, one-way analysis of variance and Pearson's correlation coefficient and for qualitative variables using chi-square analytical tests and to remove confounding variables from modeling with logistic regression method by spss version 22 software.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Honarkar Ramezani

Boushehr University of Medical Sciences

mehdihonarkarramezani@gmail.com+98 913 750 4279

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026